PharmaShots | Incisive News in 3 Shots

Subscribe Now

Irritable Bowel Syndrome

Urovant's Vibegron Fails to Meet its Primary Endpoint in P-IIa Study for IBS Pain

Urovant's Vibegron Fails to Meet its Primary Endpoint in P-IIa Study for IBS Pain

November 26, 2020

Ardelyx's Ibsrela (tenapanor) Receives the US FDA's Approval for Irritable Bowel Syndrome with Constipation (ISB-C) for Adults

Ardelyx's Ibsrela (tenapanor) Receives the US FDA's Approval for Irritable Bowel Syndrome with Constipation (ISB-C) for Adults

September 12, 2019

Ironwood and Allergan Report Positive Results of Inzess (linaclotide) in P-IIIb Trial for Patients with Irritable Bowel Syndrome with Constipation

Ironwood and Allergan Report Positive Results of Inzess (linaclotide) in P-IIIb Trial for Patients with Irritable Bowel Syndrome w...

June 19, 2019

Innovative Health Solution's IB-Stim Receives FDA's Clearance for the Treatment of Functional Abdominal Pain in Irritable Bowel Syndrome

Innovative Health Solution's IB-Stim Receives FDA's Clearance for the Treatment of Functional Abdominal Pain in Irritable Bowel Sy...

June 11, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us